EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Disentangling the heterogeneity of multiple sclerosis through identification of independent neuropathological dimensions

Alyse de Boer iD, Aletta M R van den Bosch iD, Nienke J Mekkes iD, Nina L Fransen iD, Ekaterina Dagkesamanskaia iD, Eric Hoekstra, Jörg Hamann iD, Joost Smolders iD, Inge Huitinga iD, Inge R Holtman iD

Acta Neuropathologica · 2024

DOI: 10.1007/s00401-024-02742-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Neuropathologica, 2024. Verfasst von Alyse de Boer und 9 weiteren Autor:innen. Beteiligte Einrichtung: Section Molecular Neurobiology, Department of Biomedical Sciences, University Medical Center Groningen, University of Groningen, Groningen, The Nethe…. Hauptthemen laut MEDLINE: Multiple Sclerosis. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council, Universitair Medisch Centrum Groningen, Stichting Vrienden van het Herseninstituut.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple sclerosis (MS) is a heterogeneous neurological disorder with regards to clinical presentation and pathophysiology. Here, we investigated the heterogeneity of MS by performing an exploratory factor analysis on quantitative and qualitative neuropathology data collected for 226 MS donors in the Netherlands Brain Bank autopsy cohort. Three promising dimensions were identified and subsequently validated with clinical, neuropathological, and genetic data. Dimension 1 ranged from a predominance of remyelinated and inactive lesions to extensive pathological changes, higher proportions of active and mixed lesions, and foamy microglia morphology. This pattern was positively correlated with more severe disease, the presence of B and T cells, and neuroaxonal damage. Scoring high on dimension 2 was associated with active lesions, reactive sites, and the presence of nodules. These donors had less severe disease, a specific pattern of cortical lesions, and MS risk variants in the human leukocyte antigen region, the latter indicating a connection between disease onset and this neuropathological dimension. Donors scoring high on dimension 3 showed increased lesional pathology with relatively more mixed and inactive lesions and ramified microglia morphology. This pattern was associated with longer disease duration, subpial cortical lesions, less involvement of the adaptive immune system, and less axonal damage. Taken together, the three dimensions may represent (1) demyelination and immune cell activity associated with pathological and clinical progression, (2) microglia (re)activity and possibly lesion initiation, and (3) loss of lesion activity and scar formation. Our findings highlight that a thorough understanding of the interplay between multiple pathological characteristics is crucial to understand the heterogeneity of MS pathology, as well as its association with genetic predictors and disease outcomes. The scores of donors on the dimensions can serve as an important starting point for further disentanglement of MS heterogeneity and translation into observations and interventions in living cohorts with MS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple SclerosisHumansMaleFemaleMiddle AgedAdultAgedMicrogliaBrainTissue BanksNetherlandsAutopsyCohort StudiesAged, 80 and over

Stichwörter der Autor:innen

Factor analysisGeneticsMultiple sclerosisNeuropathology

Autor:innen und Institutionen

  • Section Molecular Neurobiology, Department of Biomedical Sciences, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Neuroimmunology Research Group, Netherlands Institute for Neuroscience, Amsterdam, The Netherlands.
  • Machine Learning Lab, Data Science Center in Health, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Department of Experimental Immunology, Amsterdam Institute for Immunology and Infectious Diseases, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • MS Center ErasMS, Departments of Neurology and Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Swammerdam Institute for Life Sciences, Center for Neuroscience, University of Amsterdam, Amsterdam, The Netherlands.

ORCID-Profile: Alyse de Boer, Aletta M R van den Bosch, Nienke J Mekkes, Nina L Fransen, Ekaterina Dagkesamanskaia, Jörg Hamann, Joost Smolders, Inge Huitinga, Inge R Holtman

Förderung

  • European Research Council
  • Universitair Medisch Centrum Groningen
  • Stichting Vrienden van het Herseninstituut

Zitieren

APA

de Boer, A., van den Bosch, A. M. R., Mekkes, N. J., Fransen, N. L., Dagkesamanskaia, E., Hoekstra, E., Hamann, J., Smolders, J., Huitinga, I., & Holtman, I. R. (2024). Disentangling the heterogeneity of multiple sclerosis through identification of independent neuropathological dimensions. Acta Neuropathologica. https://doi.org/10.1007/s00401-024-02742-w

Vancouver

de Boer A, van den Bosch AMR, Mekkes NJ, Fransen NL, Dagkesamanskaia E, Hoekstra E, et al. Disentangling the heterogeneity of multiple sclerosis through identification of independent neuropathological dimensions. Acta Neuropathologica. 2024. doi:10.1007/s00401-024-02742-w

BibTeX
@article{deBoer2024,
  author = {de Boer, Alyse and van den Bosch, Aletta M R and Mekkes, Nienke J and Fransen, Nina L and Dagkesamanskaia, Ekaterina and Hoekstra, Eric and Hamann, Jörg and Smolders, Joost and Huitinga, Inge and Holtman, Inge R},
  title = {Disentangling the heterogeneity of multiple sclerosis through identification of independent neuropathological dimensions},
  journal = {Acta Neuropathologica},
  year = {2024},
  doi = {10.1007/s00401-024-02742-w}
}
Kostenlos starten →